Literature DB >> 30797062

The impact of vaccines on heterologous adaptive immunity.

N L Messina1, P Zimmermann2, N Curtis3.   

Abstract

BACKGROUND: Vaccines induce antigen-specific memory in adaptive immune cells that enables long-lived protection against the target pathogen. In addition to this, several vaccines have beneficial effects greater than protection against their target pathogen. These non-specific effects are proposed to be the result of vaccine-induced immunomodulation. In the case of bacille Calmette-Guérin (BCG) vaccine, this involves induction of innate immune memory, termed 'trained immunity', in monocytes and natural killer cells.
OBJECTIVES: This review discusses current evidence for vaccine-induced immunomodulation of adaptive immune cells and heterologous adaptive immune responses. CONTENT: The three vaccines that have been associated with changes in all-cause infant mortality: BCG, diphtheria-tetanus-pertussis (DTP) and measles-containing vaccines (MCV) alter T-cell and B-cell immunity. The majority of studies that investigated non-specific effects of these vaccines on the adaptive immune system report changes in numbers or proportions of adaptive immune cell populations. However, there is also evidence for effects of these vaccines on adaptive immune cell function and responses to heterologous stimuli. There is some evidence that, in addition to BCG, DTP and MCV, other vaccines (that have not been associated with changes in all-cause mortality) may alter adaptive immune responses to unrelated stimuli. IMPLICATIONS: This review concludes that vaccines alter adaptive immune cell populations and heterologous immune responses. The non-specific effects differ between various vaccines and their effects on heterologous adaptive immune responses may also involve bystander activation, cross-reactivity and other as yet undefined mechanisms. This has major implications for future vaccine design and vaccination scheduling.
Copyright © 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Bystander activation; Cross-reactivity; Heterologous immunity; Vaccines

Mesh:

Substances:

Year:  2019        PMID: 30797062     DOI: 10.1016/j.cmi.2019.02.016

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  21 in total

Review 1.  Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1.

Authors:  Srivamshi Pittala; Kyle S Morrison; Margaret E Ackerman
Journal:  Curr Opin HIV AIDS       Date:  2019-07       Impact factor: 4.283

Review 2.  Measles, mumps and rubella vaccine and heterologous immunity: a way out of the COVID-19 crisis?

Authors:  Jahnavi Shrivastava; Manish Narang; Sunil Gomber
Journal:  Sudan J Paediatr       Date:  2022

3.  Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.

Authors:  Nicole L Messina; Kaya Gardiner; Susan Donath; Katie Flanagan; Anne-Louise Ponsonby; Frank Shann; Roy Robins-Browne; Bridget Freyne; Veronica Abruzzo; Clare Morison; Lianne Cox; Susie Germano; Christel Zufferey; Petra Zimmermann; Katie J Allen; Peter Vuillermin; Mike South; Dan Casalaz; Nigel Curtis
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

4.  Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19.

Authors:  Pouria Mosaddeghi; Farbod Shahabinezhad; Mohammadreza Dorvash; Mojtaba Goodarzi; Manica Negahdaripour
Journal:  Hum Vaccin Immunother       Date:  2020-11-13       Impact factor: 3.452

5.  BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies.

Authors:  Esther Broset; Jacobo Pardo-Seco; Alex I Kanno; Nacho Aguilo; Ana Isabel Dacosta; Irene Rivero-Calle; Jesus Gonzalo-Asensio; Camille Locht; Luciana C C Leite; Carlos Martin; Federico Martinón-Torres
Journal:  EBioMedicine       Date:  2021-03-09       Impact factor: 8.143

6.  Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia.

Authors:  Marijana Stojanovic; Ivana Lukic; Emilija Marinkovic; Ana Kovacevic; Radmila Miljkovic; Joshua Tobias; Irma Schabussova; Mario Zlatović; Talin Barisani-Asenbauer; Ursula Wiedermann; Aleksandra Inic-Kanada
Journal:  Vaccines (Basel)       Date:  2020-12-01

7.  Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination.

Authors:  Vincenzo Puro; Concetta Castilletti; Chiara Agrati; Delia Goletti; Sara Leone; Alessandro Agresta; Eleonora Cimini; Eleonora Tartaglia; Rita Casetti; Francesca Colavita; Silvia Meschi; Giulia Matusali; Daniele Lapa; Saeid Najafi Fard; Alessandra Aiello; Chiara Farrone; Paola Gallì; Maria Rosaria Capobianchi; Giuseppe Ippolito
Journal:  Vaccines (Basel)       Date:  2021-06-08

Review 8.  COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Pediatr Infect Dis J       Date:  2020-06       Impact factor: 2.129

9.  Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.

Authors:  Michael Har-Noy; Reuven Or
Journal:  J Transl Med       Date:  2020-05-12       Impact factor: 5.531

Review 10.  Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects.

Authors:  Nora Fritschi; Nigel Curtis; Nicole Ritz
Journal:  Paediatr Respir Rev       Date:  2020-08-20       Impact factor: 2.726

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.